Exchange: OTC·Updated 11:52 AM EDT

NAVB Navidea Biopharmaceuticals Inc

$0.00
$0.00
(0.00%)
Today
Reported EarningsMar 21
Mkt Cap$100.00
Vol1,050.00

About NAVB

Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutic. It operates through the following segments: Diagnostics, Therapeutics, and Corporate. The company was founded in 1983 and is headquartered in Columbus, OH.
58

Bullish Sentiment

How do you feel about NAVB?

Advertisement|Remove ads.